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ADP   adenosine diphosphate 
ATP    adenosine triphosphate  
CABG  coronary artery bypass grafting 
CAT   catalase 
COX   cyclooxygenase 
DAG   diacylglycerol 
DNA   deoxyribonucleic acid 
DTNB   5,5'-Dithio-bis(2-nitrobenzoic acid 
EDTA   ethylenediaminetetraacetic acid 
GP   glycoprotein 
GPx   glutathione peroxidase  
GSH   reduced glutathione 
HDL   high-density lipoprotein 
5-HT   5-hidroxi-triptamin 
ICAM-1  intercellular adhesion molecule-1 
IP3   Inositol triphosphate or inositol 1,4,5-trisphosphate 
IR   insulin resistance 
LDL   low-density lipoprotein  
MLC   myosin light chain kinase 
mRNA  messenger RNA 
NO   nitric oxide or nitrogen monoxide 
NSAID  non-steroidal anti-inflammatory drug 
OCS   open canalicular system 
P47   pleckstrin 
PAD   peripheral arterial disease 
PAF   platelet activating factor 
PAI-1   plasminogen activator inhibitor-1  
PDGF   platelet derived growth factor 
PGG2   prostaglandin G2 
PGH2   prosztaglandin H2 
PGI2   prosztaglandin I2,  
PIP2   phosphatidylinositol biphosphate 
PLA2   phospholipases A2  
TCT   thrombocyte  
PMA   phorbol 12-myristate 13-acetate 
PPP   platelet poor plasma 
PRP   platelet rich plasma 
RNS   reactive nitrogen species 
ROS   reactive oxygen species 
SOD   superoxide dismutase 
T1DM   type-1 diabetes mellitus 
T2DM   type-2 diabetes mellitus 
TGF   transforming growth factor 
TIA   transient ischemic attack 
TRIS   tris(hydroxymethyl)aminomethane 
TS   thromboxane synthase 
TXA2   thromboxane A2 
Xox   Xanthine oxidase 




1. 1. Peripheral arterial disease and ischemia reperfusion injury 
The frequency of peripheral arterial disease (PAD) has been increased parallel with the 
elevation of the expected lifespan of human population. The frequency of PAD in adults 
above 50 years is 20 %. 
There are common complex pathological backgrounds of peripheral obliterative arterial 
sclerosis, the coronary sclerosis, and the disease of carotis system, though PAD patients have 
been exposed to increased risc of cardiovascular and cerebrovascular events. 
The incidence of PAD among diabetic patients is higher than in the metabolically healthy 
subjects. The complications of PAD accompanied by diabetes are more serious, than in non 
diabetic people. In spite of this comparative data of thrombocyte function and antioxidant / 
prooxidant status of type-1 and type-2 diabetic patients (T1DM, T2DM) with PAD are hardly 
found in the scientific literature. 
 
1. 2. The special feature of thrombocyte among physiological and pathological 
circumstances  
Thrombocytes have important roles in the maintenance of haemostasis, in the modulation 
of inflammation and immunity, they have bactericidal effect, they participate in wound 
healing, and tissue regeneration. At the same time platelets play a major role in acute 
ischaemic syndromes and in peripheral vascular disease. They are involved in the 
development and progression of atherosclerosis, native vessel and graft thrombosis. They 
have a central role in the development of restenosis and reocclusion after peripheral 
percutaneous transluminal angioplasty. 
The most important inducers of platelet aggregation are thromboxaneA2, adenosine 
diphosphate (ADP), collagen, thrombin, 5-hidroxi-triptamin (5-HT) and adrenaline. 
Several author described the increase of TXA synthesis in instable angina, which is 
indicative of the direct effect of spontaneous ischemia on platelet aggregation.  
ADP dependent platelet aggregation is increased in stable angina while the antiaggregating 
effects of nitrogen monoxide (NO) donors are reduced. Smoking, coronary artery diseases, 
diabetes, artheriosclerosis, hypercholesterolemia has been resulting in increased 
aggregability of platelet.  
Coronary artery diseases are more serious, if accompanied by diabetes. The endothelial layer 
maintains the equilibrium among prostanoid synthetising sysem, cyclooxigenases and 
prostaglandins. Inflammed endothelium induces the adhesion of platelet into the cell surface, 
by the increases of the expression of intercellular adhesion molecule (ICAM-1), which 
accompanied by the increased expression of α2β3 cell surface integrin in the platelet side. 
Several kind of inflammatory and mitogenic factors are secreated by thrombocyte into the 
microenvironment in the course of adhesion processes, which are able to influence the 
chemotactic, adhesive and proteolytic nature of endothelial cells. In pathological situations 
platelets can respond quickly to the changes of the endothelial cells (plack rupture, fatty 
streaks) and the exposition of subendothelial layers. 
Thrombocytes of familiar hypercholesterolemic patients are more sensitive to platelet 
agonists than it can be observed in healty people. Hypertensive and hypercholesterolemic 
patients have higher thrombomodulin level and their tombin productions are increased. The 
proaggregatory effect of oxydised LDL cholesterol was also revealed. Summarising the 
literary data, it can be concluded that several diseases accompanied by hyperaggregability of 
platelets.  
Studiing the clinical picture of different vascular diseases may results in the better 
undersending the diseases, and can provide new opportunities to find new therapeutic targets 
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for the treatmen. This was the reason why we begun to study the trombocyte function and 
antioxidant/prooxidant status of patients with peripheral arterial disease. 
  
1. 3. The biology of ischemia reperfusion injury.  
Ischemia/reperfusion injury is a relevant problem in case of thrombosis, embolisation, 
myocardial infarction, stroke, coronary bypass surgery, balloon angioplasty, thrombolysis, 
revascularization surgery of lower extremity and in every case when one segment of the 
vessels are excluded from the circulation, and than reopened. The vessel closure and the 
consecutive ischemia can be caused by arterial thrombosis (which originated from 
embolisation, stenotic arteriopathy or trauma), artérial spasmus, external compression, or 
anatomic alteration.  
The tolerance of tissues to ischemia varies with the nature of the tissues and depends on the 
presence or absence of the collateral flow. Ischemia/reperfusion injury of skeletal muscles 
leads to an acute inflammation, which not only affects the nutritional territory of affected 
vessel, but also causes remote organ injury.  
The acidosis, which occurs in the ischemic area, causes tissue injury or cell death. The 
remaining tissues adapted to the oxygen poor environment by changing their metabolic state 
form aerobic to anaerobic, but finaly this strategy can lead to further tissue injury and cell 
death. The masure of tissue injuries are depend on the duration of hypoxia, the amount of the 
tissues are involved, and the systemic arterial peressure.  
The restoration of the blood flow is the only way to salvage the tissue from the devastation, but it 
can not be made without risk, because of the accompanied volume, pressure, and metabolic 
stress. The main component of the pathophysiological molecular cascade is the neutrophyl 
activation, and the rsulted free radical production (reactive oxygen and nitrogen species (ROS, 
NOS respectively), and the elevated intracellular Ca2+ levels. In the early phase of reperfusion a 
sharp increase in the proinflammatory cytokines occurs. Tese factors all together threat the 
integrity of the organism, due to the damage of the key macromolecules (proteins, lipids and 
nucleic acids). The final results are the disintegration of the membranes which are responsible 
for the intracellular compartementalisation, rhe injured ion transport, the injury of the contractile 
elements and the insufficient mitochondrial energy production.  
 
2. The aims of the dissertation: 
 
1. In the first part of our study we aimed to monitor the function of thrombocytes, the 
endogenous antioxidants (SOD, GSH, plasma total thiol group concentrations) and 
prooxidants (free radical production of whithe blood cells, MDA levels in red blood cell 
haemolysates and plasma, myeloperoxidase) levels in the perioperative period of emergency 
(12 patients; Acute group) and elective (10 patients; Elective group) revascularization 
surgery of lower limb. Similar values of 10 healthy blood donors (control group) were also 
considered. 
In this prospective randomysed open study the trombocyte function was measured by two 
different techniques, in whole blood and in platelet rich plasma. 
We investigated the time dependent changes of thrombocyte function and 
prooxidant/antioxidant status in the perioperative phase of revascularization surgery of lower 
limb.The interaction of the thrombocyte and the other circulating cells were also 
investigated. 
 
2. PAD is frequently accompanied by diabetes, hypertension, and smooking caused lung 
disorders, as we observed in the first row of experiments and in the scientific literature. In 
the second part of our studies thrombocyte function, prooxidant/ antioxidant status of type 1 
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and type 2 diabetic patients with PAD (T1DM; T2DM, respectively) were compared to each 
other (altogether 46 patients) and to the parameters of 11 healthy blood donors. The reason 
of our investigation was, that only a few systematic, comparative data can be found in the 
literature about the thrombocyte function, and oxidative stress staus of T1DM; T2DM 
patients with PAD. 
 
3. Monitoring thrombocyte function and oxidative stress markers in the course of 
revascularization surgery of lower limb  
 
3.1. Patients 
Patients in the Acute group suffered from serious lower limb ischemia for several hours (4–6 
hours) before surgery. In 8 patients the cause of ischemia was clear embolism, which was 
solved by Fogarty’s embolectomy. The other patients had an acute arterial thrombosis at the 
level of femoral artery and one rupture of infrarenal aortic aneurism was also involved. 
Patients of the Elective group were scheduled for revascu larization surgery because of 
obliterative arterial disease with consequential ischemia at the level of superficial femoral 
artery, which was improved by angiographic and Doppler measurements. The surgical 
solutions were similar in all of these cases, with 42,8±16,3 min exclusion time. 
All patients received antiplatelet therapy (at least 75 mg Aspirin) before the recruitment. 
Low molecular weight heparin was prescribed in the perioperative period. 
All patients were taking part in the study had been operated in the Department of General 
and Vascular Surgery, Baranya County Hospital in Pecs. Laboratory measurements were 
carried out in Department of Surgical Research and Techniques of Pecs University. The 
average age was 58,1 ± 7,3 years. Peripheral blood samples had been taken before,  2 and 24 
hours after the surgery, as well as one week after operation.  
 
3. 2. Measurement of platelet aggregation and endogenous antioxidants and prooxidants. 
 
-Measurement of platelet aggregation: 
Platelet aggregation in platelet rich plasma (PRP) was measured by the turbidimetric method 
of Born, by a four-channel aggregometer (Carat TX4 instrument, Carat Diagnostics Ltd. 
Budapest, Hungary). ADP (5 and 10 µM) and collagen (2 µg/ml) were used as aggregation 
inductors. The results were expressed as percentage of 100 % aggregation. 
Platelet aggregation in whole blood was measured by two-channel impedance aggregometer 
(Chrono-log aggregométer, USA), according to the user’s manual of the instrument. 
ADP (5 µM) or collagen (2 µg/ml) were used as inductors. The development of aggregation 
was recorded for six minutes and was expressed in Ohm. 
 
- Measurement of prooxidants: 
Free radical production of leucocytes was induced by phorbol miristate acetate (PMA) in 
whole blood, and was followed by luminometric method by Chrono-Log 
luminoaggregometer. 
 
Malondialdehyde (MDA) levels in red blood cell hemolysate and in plasma, and 
myeloperoxidase (MPO) levels in plasma, were measured by standard photometric methods. 
 
-Measurement of antioxidants: 
Measurement of reduced glutathione (GSH) and plasma thiol (SH) groups: 
GSH and plasma SH level were determined in anticoagulated whole blood (EDTA) by 
Ellman’s reagent according to the photometric method of Sedlak and Linsday. 
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Measurement of superoxide dismutase (SOD) activity in washed red blood cells haemolysate 
(RBC): The main principle of this measurement was that adrenaline is able to spontaneously 
transform to adrenochrome (a detectable colourful complex). This transformation can be 
blocked by SOD and SOD containing cells or tissues. The difference in the rate of rise of 




The results were expressed as mean ± SD or in percentage. The differences were calculated 
by paired and unpaired Student’s t-test, and by one way analyses of variance. The alterations 
were considered significant when p values were less than 0,05. 
 
 
3. 5. Results: 
3. 5. 1. Aggregation in platelet rich plasma 
Aggregation measurement made possible to study thrombocyte function independently from 
the effects of other circulating cells. 
Before surgery ADP induced maximal aggregation in PRP was reduced in both Acute and 
Elective groups compared to the Control group (p<0.05). This trend prevailed in the course 
of the study. The same pattern occurred in case of collagen induced aggregation, as well. 




3. 5. 2. Aggregation measurement in whole blood: 
The reduced aggregation, was observed in patients groups in response to ADP and collagen 
compared to healthy people’s PRP, had not been observed in whole blood. ADP and 
collagen induced aggregation in patients groups were comparable to Control group before 
the surgery and 2 and 24 hours after it, in whole blood. A statistically highly significant 
elevation appeared in Acute group in response to ADP and collagen induced aggregation, 
one week after the surgery, compared to elective and control groups, and to its own baseline 
values, as well. 
 
 
3.5. 3. Prooxidants: 
 
-PMA-induced ROS production in whole blood: 
Addition of PMA to several cell types (among others circulating blood cells, such as 
granulocytes, neutrophil cells, and platelets), resulted in increased ROS production due to 
activation of NADPH oxidase enzyme. The main sources of ROS in the blood stream are 
the leucocytes. White blood cell counts were moderately elevated in the two patient 
groups in the whole period of the study (p<0.05). Before surgery, ROS production was 
disproportionately high in the Acute group considering the mild elevation of leucocyte 
numbers, signed an extreme increase in the free radical producing capacity of the 
indivividual leucocytes in this case. This elevated amount of free radicals increased 
further in the course of the study, reaching a twenty- to fortyfold elevation compared to 
healthy Controls or the Elective group (p<0.01). Significant elevation was also observed 
in maximum free radical production in the Elective group at the end of the week, but it 
did not exceed the twofold elevation. The lag time of ROS production in the Acute group 
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was significantly shorter before surgery compared to the other two groups, and shortened 
further in the early reperfusion. In the Acute group, the slope of the free radical 
generation curve was steeper at each time point than in the other two groups. Significant 
elevation in the slope of free radical production was observedin the Elective group as 
well, one week after the surgery.  
 
 
- MDA levels inred blood cell hemolysate and in plasma  
Reactive oxygen species degrade polyunsaturated lipids; forming malondialdehyde The 
production of this aldehyde is used as a biomarker to measure the level of oxidative stress in 
an organism. A significant elevation in MDA level was observed in the Elective group in the 
early phase of reperfusion compared to baseline level and to the Control (p<0.05). In the 
Acute group a standard low level of MDA was measured in the perioperative phase. The 
value was low before the surgery as well, signed the lack of unsaturated fatty acids in the 
membrane. In our study plasma MDA levels increased significantly in patients groups.In the 
Acute group plasma MDA levels were higher than it was measured in Elective and Control 
groups(p<0.05). Plasma MDA level of Elektív was higher than in Control, but it returned 
into the Control level one week after the surgery. 
 
- Myeloperoxidase (MPO) is a hydrogen peroxide oxidoreductase, specifically found on 
mammalian granulocytic leucocytes, including polymorphonuclear leucocytes (PMN), 
basophils and eosinophils, responsible for the bacteriocidal capability of these cells. PMN 
activation and mediator release are partially responsible for the morbidity and mortality of 
revascularization of ischemic lower limb, regardless of the mode of intervention, surgical or 
thrombolytic. 
In our cases plasma myeloperoxidase levels were higher in both patient groups at each time 
point compared to control. In a very new study was improved that myeloperoxidase, but not 
C-reactive protein, predicts cardiovascular risk in peripheral arterial disease. In our study 
MPO level in both patients groups were higher, than in Control group. After a transient 
reduction MPO level it returned to the levels were measured before the surgery in the 
surgery . 
 
3. 5. 4. Changes in endogenous antioxidants: 
 
- Superoxyde dismutase (SOD): 
SOD activity was lower in patients groups compared to Control, even before the surgery, 
and these low levels decreased further in the early reperfusion. In Acute group SOD level 
were lower than it was measured in Elective group, as well. 
  
- Reduced glutathione (GSH) levels and the concentration of plasma sulphydril groups 
 
GSH levels in the three investigared groups were similar before the surgery in both patient 
groups, and decreased transiently during the early reperfusion, but it returned to the baseline 
by the end of the week. The concentrations of plasma –SH groups followed similar pattern.  
 
 
3. 6. Summary and conclusion: 
Restoration of the blood flow in the formerly ischemic tissues is initiates several 
complication, involving local and systemic responses. Ischemia/reperfusion injury was 
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described almost 50 years before, but the correct mediation, the way of prevention or 
treatmen is under investigation in nowdays, as well. 
In the course of the ischemia reperfusion injury of lower limb, muscle changes is 
accompanied by a progressive microvascular damage.The inflammatory response following 
reperfusion vary greatly and depends on the time and severity of ischemia, as it was 
measured in our cases too. 
To study the ischemia/reperfusion induced injury of revascularization surgery of patients 
with peripheral arterial diseases after acute critical limb ischemia and in the course of 
elective revascularization surgery were in the focus of the present study. According to our 
results in accordance with several other studies, the duration and severity of ischemia is 
proportional to the damage occurred after it. Studiing thrombocyte function and antioxidant 
prooxidant status of our unique patient groups, several new aspects of ischemia reperfusion 
injury were revealed. Peripheral artery disease is a common progressive disorder that 
attaches the circulation of the legs, particularly in people over 55 years, strengthening in 
these patients the greatly increased risk of heart attack or stroke, and of dying within a 
decade. Several aspects of the problem were intensively studied, but platelet function during 
the restoration of the circulation of ischemic lower limb was hardly invesbefore. 
 
4. MONITORING THROMBOCYTE FUNCTION AND ANTIOXIDANT 
PROOXIDANT STATUS IN DIABETIC PERIPHERAL ARTERIAL DISEASES.  
 
4. 1. Introduction 
Diabetes mellitus is a potent risk factor for the development of a wide spectrum of 
cardiovascular (CV) complications. The complex metabolic milieu accompanying diabetes 
alters blood rheology, the structure of arteries and disrupts the homeostatic functions of the 
endothelium. 
Diabetes and PAD are frequently accompanied by each other. The duration of diabetes 
correlate well with the seriousness of the PAD. Among diabetic people oftener the 
infrapopliteral arterial occlusion than in the nondiabetic patients. 
The presence of diabetes increases the frequency of intermittent claudication.The relative 
risk of amputation in diabetic population is 12,4-fold higher compared to the nondiabetic 
patients (95%, 10,9-14,9), and this value doubles above 65 years. 
 
4. 2. Aim of study. 
The aim of the second part of our study was to compare the thrombocyte function and 
antioxidant/prooxidant status of type 1, and type 2 diabetic patients with PAD. 
 
4.3. Materials and methods: 
4. 3. 1. Patients 
Diabetic patients involved in this study were selected randomly from the diabetic outpatients 
with peripheral arterial diseas of Department of General and Vascular Surgery, Baranya 
County Hospital in Number of patients was 24 in T1DM, and 22 in T2DM groups. Ten 
healthy blood donors were involved as controls.  
T1DM patients received insulin and T2DM patients received oral antidiabteic agents as 
antidiabetic terapy, with the exeption of two patients who received insulin, as well.. All of 
the patients received antiplatelet agents. In T1DM group 4 patients received Syncumar as 
anticoagulant, and other 14 received low molecular weight heparine. In T2DM group all 
patients were received antiplatelet therapy, 4 patients were treated by Syncumar and 10 with 






The same methods were used as in 3.2. 
 
4.4. Statistics: 
The results were expressed as mean ± SD or in percentage. The differences were calculated 
by paired and unpaired Student’s t-test, and by one way analyses of variance. The alterations 
were considered significant when p values were less than 0,05. 
The areas under the platelet aggregation curves were calculated in whole blood by 
Microcal/Origin 6.0 professional program. By means of this program linear regression 
analyses were made and correlation was determined the serum glucose levels of the patients 




4.5.1. Clinical chemistry data 
 
Fasted serum glucose and triglyceride levels were higher than the normal values. The mean 
value of cholesterol level was within the normal range, but individually high values were 
measure, as well. The elevated fibrinogen levels were measured in both groups were 
considered as a sign of increased aggregability. The highest white blood cell counts were 
measured in T1DM (11,2 ± 1,3 x 104 cell/µl3), which was significantly higher than in the 
control group (6,71 ± 0,32 x 104 sejt/µl3), (p<0.01). The white blood cell count in the T2DM 
group was 8,92 ± 0,99 x 104 cell/µl3.  
 
4.5.2. Thrombocyte function in PRP:  
 
ADP and collagen induced aggregation was significantly reduced in isolated platelets of both 
diabetic patients groups, compared to control group. The reduction was less pronounced in 
T2DM diabetic patients.  
 
4.5.3. Investigation of aggregation in whole blood 
 
ADP induced aggregation was higher in both patients groups,and Collagen induced 
aggregation was increased in T1DM patients compared to Control. 
Similarly to our previous data, platelet aggregation measure in PRP reflected a satisfactory 
antiplatelet therapy, but in whole blood these differences can not be observed. 
Our data revealed that measurement of aggregation in platelet rich plasma and in whole 
blood parallel is usefull for the exploration of therapeutic defect. In spite of the effectivity of 
antiplatelet therapy, was observed in isolated thrombocytes, the other circulating cells, such 
as white blood cells, can bypass in a paracrine manner the antiplated therapy, and my be 
induce platelet aggregation by free radicals or by their own resynthetised COX enzymes. 
Significant linear correlation was improved in T1DM patients fasted serum glucose level and 







4. 5. 4. Results of the prooxidant measurement 
 
-  PMA-induced free radical production: 
In the control group the PMA induced ROS production corrected to white blood cell counts 
were minimal (9,072 ± 2,36 AU/103 , but In T1DM group a twentyfold elevation was 
measured in ROS production compared to control. ROS production in T2DM group was five 
times higher than it was observed in Control.  
 
4. 5. 5. Results of the antioxidant measurements 
 
SOD and GSH levels were reduced in both diabetic groups, which supposed to be an 
important determinant of the diabetes caused systemic oxidative stress. The reduction of 
SOD activity was independent from the type of diabetes. 




5. NOVEL FINDINGS: 
1. Our study primarily monitored the effect of ischemia reperfusion injury on thrombocyte 
function and on prooxydant status in the whole hospitalization phase of emergency and 
elective revascularization surgery of lower limb. In the course of our study we revealed that 
satisfactory inhibition in the level of isolated thrombocita dos not means definite prevention 
of thrombus formation, because of the modulatory role of cellular and non cellular 
components of the blood.  
 
2. We demonstrated a robust significant elevation in ADP and Collagen induced aggregation 
in whole blood one week after revascularization surgery of lower limb, in spite of the 
inhibited platelet aggregation was measured in PRP.This was accompanied by the low level 
of antioxidant enzyme and a permanent increase in ROS production. Similar phenomenon 
was not observed in elective patients.. 
 
3. We demonstared that the restoration of the circulation in PAD patients with serious limb 
ischemia did not followed by the restoration of antioxidant /prooxidant satus. 
 
4. Our measures reveal significant differences in thrombocyte function of T1DM and T2DM, 
patients with PAD and improved that area under curves of T1DM correlate well with the 
serum glucose levels of these patients.  
 
5. SOD deficiency was demonstrated in our study was independent of the type of diabetes. 
  
6. PMA – induced ROS production was significantly higher in diabetic patients. It can be 
considered as novel finding, that free radical production of T1DM group was significantly 
higher than in T2DM patients.  
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